Presepsin as a predictor of septic shock in patients with urinary tract infection

被引:11
作者
Sekine, Yoshitaka [1 ]
Kotani, Kazuhiko [2 ]
Oka, Daisuke [1 ]
Nakayama, Hiroshi [1 ]
Miyazawa, Yoshiyuki [1 ]
Syuto, Takahiro [1 ]
Arai, Seiji [1 ]
Nomura, Masashi [1 ]
Koike, Hidekazu [1 ]
Matsui, Hiroshi [1 ]
Shibata, Yasuhiro [1 ]
Murakami, Masami [3 ]
Suzuki, Kazuhiro [1 ]
机构
[1] Gunma Univ, Dept Urol, Grad Sch Med, 3-39-22 Showa Machi, Maebashi, Gumma 3718511, Japan
[2] Jichi Med Univ, Div Community & Family Med, Dept Clin Lab Med, Shimotsuke, Tochigi, Japan
[3] Gunma Univ, Dept Clin Lab Med, Grad Sch Med, Maebashi, Gumma, Japan
关键词
Bacterial infections; Biomarkers; C-reactive protein; Cytokines; Endotoxins; Flank pain; Presepsin; Urinary tract infection; Sepsis; procalcitonin; SEPSIS; PROCALCITONIN; DEFINITIONS;
D O I
10.1186/s12894-021-00906-4
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background Recently, presepsin has been reported to be a useful biomarker for early diagnosis of sepsis and evaluation of prognosis in septic patients. However, few reports have evaluated its usefulness in patients with urinary tract infections (UTI). This study aimed to evaluate whether presepsin could be a valuable marker for detecting severe sepsis, and whether it could predict the therapeutic course in patients with UTI compared with markers already used: procalcitonin (PCT) and C-reactive protein (CRP). Methods From April 2014 to December 2016, a total of 50 patients with urinary tract infections admitted to Gunma university hospital were enrolled in this study. Vital signs, presepsin, PCT, CRP, white blood cell (WBC) count, causative agents of urinary-tract infections, and other data were evaluated on the enrollment, third, and fifth days. The patients were divided into two groups: with (n = 11) or without (n = 39) septic shock on the enrollment day, and with (n = 7) or without (n = 43) sepsis on the fifth day, respectively. Presepsin was evaluated as a biomarker for systemic inflammatory response syndrome (SIRS) or septic shock. Results Regarding the enrollment day, there was no significant difference of presepsin between the SIRS and non-SIRS groups (p = 0.276). The median value of presepsin (pg/mL) was significantly higher in the septic shock group (p < 0.001). Multivariate logistic regression analysis showed that presepsin (>= 500 pg/ml) was an independent risk factor for septic shock (p = 0.007). ROC curve for diagnosing septic shock indicated an area under the curve (AUC) of 0.881 for presepsin (vs. 0.690, 0.583, and 0.527 for PCT, CRP and WBC, respectively). Regarding the 5th day after admission, the median presepsin value on the enrollment day was significantly higher in the SIRS groups than in the non-SIRS groups (p = 0.006). On the other hand, PCT (>= 2 ng/ml) on the enrollment day was an independent risk factor for SIRS. ROC curve for diagnosing sepsis on the fifth day indicated an AUC of 0.837 for PCT (vs. 0.817, 0.811, and 0.802 for presepsin, CRP, and WBC, respectively). Conclusions This study showed that presepsin may be a good marker for diagnosing septic shock based on admission data in patients with UTI.
引用
收藏
页数:7
相关论文
共 21 条
  • [1] Influence of renal dysfunction on the accuracy of procalcitonin for the diagnosis of postoperative infection after vascular surgery
    Amour, Julien
    Birenbaum, Aurelie
    Langeron, Olivier
    Le Manach, Yannick
    Bertrand, Michele
    Coriat, Pierre
    Riou, Bruno
    Bernard, Maguy
    Hausfater, Pierre
    [J]. CRITICAL CARE MEDICINE, 2008, 36 (04) : 1147 - 1154
  • [2] Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care
    Angus, DC
    Linde-Zwirble, WT
    Lidicker, J
    Clermont, G
    Carcillo, J
    Pinsky, MR
    [J]. CRITICAL CARE MEDICINE, 2001, 29 (07) : 1303 - 1310
  • [3] DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    [J]. CHEST, 1992, 101 (06) : 1644 - 1655
  • [4] Kinetics of procalcitonin in iatrogenic sepsis
    Brunkhorst, FM
    Heinz, U
    Forycki, ZF
    [J]. INTENSIVE CARE MEDICINE, 1998, 24 (08) : 888 - 889
  • [5] Plasmatic presepsin (sCD14-ST) concentrations in acute pyelonephritis in adult patients
    Claessens, Yann-Erick
    Trabattoni, Eloise
    Grabar, Sophie
    Quinquis, Laurent
    Sahakian, Guillaume Der
    Anselmo, Marine
    Schmidt, Jeannot
    de la Coussaye, Jean-Emmanuel
    Plaisance, Patrick
    Casalino, Enrique
    Potel, Gilles
    Lecomte, Francois
    Borderie, Didier
    Chenevier-Gobeaux, Camille
    [J]. CLINICA CHIMICA ACTA, 2017, 464 : 182 - 188
  • [6] PROCALCITONIN INCREASE AFTER ENDOTOXIN INJECTION IN NORMAL SUBJECTS
    DANDONA, P
    NIX, D
    WILSON, MF
    ALJADA, A
    LOVE, J
    ASSICOT, M
    BOHUON, C
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (06) : 1605 - 1608
  • [7] Multi-marker approach using procalcitonin, presepsin, galectin-3, and soluble suppression of tumorigenicity 2 for the prediction of mortality in sepsis
    Kim, Hanah
    Hur, Mina
    Moon, Hee-Won
    Yun, Yeo-Min
    Di Somma, Salvatore
    [J]. ANNALS OF INTENSIVE CARE, 2017, 7
  • [8] Interpretation of C-Reactive Protein Concentrations in Critically Ill Patients
    Lelubre, Christophe
    Anselin, Sophie
    Boudjeltia, Karim Zouaoui
    Biston, Patrick
    Piagnerelli, Michael
    [J]. BIOMED RESEARCH INTERNATIONAL, 2013, 2013
  • [9] Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study
    Levy, Mitchell M.
    Artigas, Antonio
    Phillips, Gary S.
    Rhodes, Andrew
    Beale, Richard
    Osborn, Tiffany
    Vincent, Jean-Louis
    Townsend, Sean
    Lemeshow, Stanley
    Dellinger, R. Phillip
    [J]. LANCET INFECTIOUS DISEASES, 2012, 12 (12) : 919 - 924
  • [10] Maruna P, 2000, PHYSIOL RES, V49, pS57